Alec W Freyn

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Top Venues

Science translational medicine

Proceedings of the National Academy of Sciences of the United States of America

Nature medicine

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Alec W Freyn, Caroline Atyeo, Patricia L Earl, Jeffrey L Americo, Gwo-Yu Chuang, Harini Natarajan, Tiffany R Frey, Vrc Production Program, Juan I Moliva, Ruth Hunegnaw, Guha Asthagiri Arunkumar, Clinton O Ogega, Arshan Nasir, Genesis Santos, Rafael H Levin, Anusha Meni, Patricia A Jorquera, Hamilton Bennett, Joshua A Johnson, Michael A Durney, Guillaume B E Stewart-Jones, Jay W Hooper, Tonya M Colpitts, Galit Alter, Nancy J Sullivan, Andrea Carfi, Bernard Moss
An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge. Science translational medicine 15 (716) (2023)
Alec W Freyn, Julianna Han, Jenna J Guthmiller, Mark J Bailey, Karlynn Neu, Hannah L Turner, Victoria C Rosado, Veronika Chromikova, Min Huang, Shirin Strohmeier, Sean T H Liu, Viviana Simon, Florian Krammer, Andrew B Ward, Peter Palese, Patrick C Wilson, Raffael Nachbagauer
Influenza hemagglutinin-specific IgA Fc-effector functionality is restricted to stalk epitopes. Proceedings of the National Academy of Sciences of the United States of America 118 (8) (2021)
Jenna J Guthmiller, Julianna Han, Lei Li, Alec W Freyn, Sean T H Liu, Olivia Stovicek, Christopher T Stamper, Haley L Dugan, Micah E Tepora, Henry A Utset, Dalia J Bitar, Natalie J Hamel, Siriruk Changrob, Nai-Ying Zheng, Min Huang, Florian Krammer, Raffael Nachbagauer, Peter Palese, Andrew B Ward, Patrick C Wilson
First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopes. Science translational medicine 13 (596) (2021)
Pauline Maisonnasse, Yoann Aldon, Aurélien Marc, Romain Marlin, Nathalie Bosquet, Natalia A Kuzmina, Alec W Freyn, Jonne L Snitselaar, Antonio Gonçalves, Tom G Caniels, Judith A Burger, Meliawati Poniman, Ilja Bontjer, Virginie Chesnais, Ségolène Diry, Anton Iershov, Adam J Ronk, Sonia Jangra, Raveen Rathnasinghe, Philip J M Brouwer, Tom P L Bijl, Jelle van Schooten, Mitch Brinkkemper, Hejun Liu, Meng Yuan, Chad E Mire, Mariëlle J van Breemen, Vanessa Contreras, Thibaut Naninck, Julien Lemaître, Nidhal Kahlaoui, Francis Relouzat, Catherine Chapon, Raphaël Ho Tsong Fang, Charlene McDanal, Mary Osei-Twum, Natalie St-Amant, Luc Gagnon, David C Montefiori, Ian A Wilson, Eric Ginoux, Godelieve J de Bree, Adolfo García-Sastre, Michael Schotsaert, Lynda Coughlan, Alexander Bukreyev, Sylvie van der Werf, Jeremie Guedj, Rogier W Sanders, Marit J van Gils, Roger Le Grand
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models. Nature communications 12 (1) (2021)
Raffael Nachbagauer, Jodi Feser, Abdollah Naficy, David I Bernstein, Jeffrey Guptill, Emmanuel B Walter, Franceso Berlanda-Scorza, Daniel Stadlbauer, Patrick C Wilson, Teresa Aydillo, Mohammad Amin Behzadi, Disha Bhavsar, Carly Bliss, Christina Capuano, Juan Manuel Carreño, Veronika Chromikova, Carine Claeys, Lynda Coughlan, Alec W Freyn, Christopher Gast, Andres Javier, Kaijun Jiang, Chiara Mariottini, Meagan McMahon, Monica McNeal, Alicia Solórzano, Shirin Strohmeier, Weina Sun, Marie Van der Wielen, Bruce L Innis, Adolfo García-Sastre, Peter Palese, Florian Krammer
A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial. Nature medicine 27 (1) (2020)